4.36 A Randomized, Double-Blind, Placebo-Controlled Study of the D1 Receptor Antagonist Ecopipam for Children and Adolescents With Tourette's Disorder

D1 Receptor ◽

Controlled Study ◽

Tourette’S Disorder ◽

Double Blind ◽

Double Blind Placebo ◽

Tourette's Disorder ◽

D1 Receptor Antagonist

Faculty of 1000 evaluation for A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with tourette's disorder.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718129292.793486633 ◽

2013 ◽

Author(s):

Cynthia Comella

Keyword(s):

Controlled Study ◽

Tourette’S Disorder ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty of 1000 evaluation for A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with tourette's disorder.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718129292.793486087 ◽

2013 ◽

Author(s):

Olivier Rascol ◽

Santiago Perez-Lloret

Keyword(s):

Controlled Study ◽

Tourette’S Disorder ◽

Double Blind ◽

Double Blind Placebo ◽

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in Children and Adolescents With Tourette’s Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.12m08189 ◽

2013 ◽

Vol 74 (08) ◽

pp. e772-e780 ◽

Cited By ~ 76

Author(s):

Hanik K. Yoo ◽

Yoo Sook Joung ◽

Jeong-Seop Lee ◽

Dong Ho Song ◽

Young Sik Lee ◽

...

Keyword(s):

Controlled Study ◽

Tourette’S Disorder ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718129292.793486082 ◽

2013 ◽

Author(s):

Joseph Jankovic ◽

Mary Ann Thenganatt

Keyword(s):

Controlled Study ◽

Tourette’S Disorder ◽

Double Blind ◽

Double Blind Placebo ◽

A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2016.04.012 ◽

2016 ◽

Vol 118 (3) ◽

pp. 160-166 ◽

Cited By ~ 12

Author(s):

Tanya Khasnavis ◽

Rosa J. Torres ◽

Barbara Sommerfeld ◽

Juan Garcia Puig ◽

Richard Chipkin ◽

...

Keyword(s):

Receptor Antagonist ◽

Crossover Trial ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Double Blind ◽

Double Blind Placebo ◽

Selective Dopamine ◽

D1 Receptor Antagonist

Multicenter, Double-Blind, Placebo-Controlled Study of Mecamylamine Monotherapy for Tourette's Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1097/00004583-200109000-00020 ◽

2001 ◽

Vol 40 (9) ◽

pp. 1103-1110 ◽

Cited By ~ 79

Author(s):

ARCHIE A. SILVER ◽

R. DOUGLAS SHYTLE ◽

KATHY H. SHEEHAN ◽

DAVID V. SHEEHAN ◽

AMAYA RAMOS ◽

...

Keyword(s):

Controlled Study ◽

Tourette’S Disorder ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2016.0026 ◽

2017 ◽

Vol 27 (9) ◽

pp. 771-781 ◽

Cited By ~ 42

Author(s):

Floyd Sallee ◽

Eva Kohegyi ◽

Joan Zhao ◽

Robert McQuade ◽

Kevin Cox ◽

...

Keyword(s):

Controlled Trial ◽

Efficacy And Safety ◽

Tourette’S Disorder ◽

Double Blind ◽

Double Blind Placebo ◽

PM308. A phase 3, multicenter randomized double blind placebo controlled study of the opioid receptor antagonist –Odelepran the treatment of alcohol addiction.

The International Journal of Neuropsychopharmacology ◽

10.1093/ijnp/pyw041.308 ◽

2016 ◽

Vol 19 (Suppl_1) ◽

pp. 10-10 ◽

Cited By ~ 1

Keyword(s):

Receptor Antagonist ◽

Opioid Receptor ◽

Alcohol Addiction ◽

Controlled Study ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Opioid Receptor Antagonist

Probiotics improve atopic dermatitis in children and adolescents: a double blind, placebo-controlled study.

10.22541/au.158930908.86661145 ◽

2020 ◽

Author(s):

Paula Danielle Santa Maria Albuquerque de Andrade ◽

Jorgete Maria e Silva ◽

Vanessa Carregaro ◽

La s Sacramento ◽

Luciana Roberti ◽

...

Keyword(s):

Atopic Dermatitis ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2017.10.006 ◽

2017 ◽

Vol 56 (12) ◽

pp. 1015-1025 ◽

Cited By ~ 35

Author(s):

Melissa P. DelBello ◽

Robert Goldman ◽

Debra Phillips ◽

Ling Deng ◽

Josephine Cucchiaro ◽

...

Keyword(s):

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo